Bulletin
Investor Alert

Market Pulse Archives

Feb. 13, 2018, 9:59 a.m. EST

Dare Bioscience's stock plunges to pace all decliners after stock offering

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Dare Bioscience Inc. (DARE)
  • X
    Helios & Matheson Analytics Inc. (HMNY)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Shares of Dare Bioscience Inc. /zigman2/quotes/203460984/composite DARE -3.25% plummeted 41% toward a record low Tuesday, enough to make them the day's biggest decliners on major U.S. exchanges, after the biopharmaceutical company announced a public stock offering. The second-biggest decliners were shares of Helios & Matheson Analytics Inc. /zigman2/quotes/208158842/composite HMNY +9,900% , which plunged 29% after an equity offering. Dare said it was raising $10.25 million with its offering, which included 5.0 million common shares and warrants to buy 3.5 million common shares. That could potentially more than double the number of shares outstanding, which totaled 6.05 million shares as of Nov. 6. Dare's stock has now tumbled 89.3% over the past 12 months, while the S&P 500 /zigman2/quotes/210599714/realtime SPX +1.06% has gained 13.5%.

/zigman2/quotes/203460984/composite
US : U.S.: Nasdaq
$ 1.19
-0.04 -3.25%
Volume: 773,481
July 1, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$100.81 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/208158842/composite
US : U.S.: OTC
$ 0.0001
+0.0001 +9,900%
Volume: 20.00
June 30, 2022 12:15p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
N/A
Rev. per Employee
N/A
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,825.33
+39.95 +1.06%
Volume: 2.20B
July 1, 2022 5:45p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.